Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 1/20 | 0.55 |
| ▸ | KIF11 | P52732 | 2/20 | 0.53 |
| ▸ | PARP14 | Q460N5 | 16/20 | 0.52 |
| ▸ | JAK2 | O60674 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | KLK7 | P49862 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28887355 | 0.87 | KIF11 (0.59) | BCHEKIF11PARP14JAK2TP53 | |
| SCHEMBL4580549 | 0.85 | PARP14 (0.48) | BCHEKIF11PARP14TP53 | |
| SCHEMBL9490444 | 0.85 | KIF11 (0.59) | KIF11PARP14JAK2TP53MAPT | |
| SCHEMBL29986487 | 0.83 | BCHE (0.64) | BCHEKIF11PARP14 | |
| SCHEMBL147411 | 0.83 | BCHE (0.64) | BCHEKIF11PARP14 | |
| SCHEMBL28937735 | 0.83 | ALDH1A1 (0.52) | TP53MAPT | |
| SCHEMBL30332497 | 0.83 | ALDH1A1 (0.52) | TP53MAPT | |
| SCHEMBL22189181 | 0.83 | PARP14 (0.51) | KIF11PARP14JAK2TP53MAPT | |
| SCHEMBL30022189 | 0.83 | PARP14 (0.51) | KIF11PARP14JAK2TP53MAPT | |
| SCHEMBL28887348 | 0.81 | KIF11 (0.62) | BCHEKIF11PARP14JAK2TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12590249-B2 | Etchant composition | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2026-03-31 | — | — | US | claimed |
| US-20220025261-A1 | ETCHANT COMPOSITION | SOULBRAIN CO., LTD. (KR) | 2022-01-27 | — | — | US | claimed |
| US-12590249-B2 | Etchant composition | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2026-03-31 | — | — | US | disclosed |
| US-20220025261-A1 | ETCHANT COMPOSITION | SOULBRAIN CO., LTD. (KR) | 2022-01-27 | — | — | US | disclosed |
| US-11142694-B2 | Etchant composition and method of fabricating semiconductor device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2021-10-12 | — | — | US | disclosed |
| US-20200216758-A1 | ETCHANT COMPOSITION AND METHOD OF FABRICATING SEMICONDUCTOR DEVICE | SOULBRAIN CO., LTD. (KR) | 2020-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12590249-B2 | Etchant composition | ASIC1, NOS1, CA1 | BCHE 3310/4885KIF11 3245/4885PARP14 4649/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.